Steps for obtaining biospecimens from the LCBRN
The investigator and home institution must agree to the provisions in the LCBRN Investigator Agreement. The LCBRN and the institutions which procure specimens for the LCBRN make no claim to intellectual property derived from the use of these specimens. However, the specimens and direct derivatives of the specimens (DNA, RNA, protein, etc.) may not be sold, and may not be transferred to a third party without consent from the LCBRN.
PLEASE NOTE: No modifications to this agreement are allowed. The LCBRN will not be able to provide samples to individuals and institutions that do not agree to abide by the unaltered specifications in this document. Any application will not be considered until the Investigator Agreement is signed and returned.
The LCBRN Application must be completed and returned. The type and number of biospecimens requested must be justified. The biosamples of the LCBRN are a valuable and finite resource; therefore, the LCBRN Scientific Review Panel, which includes all LCBRN P.I.s and several academic faculty with funded lung cancer research programs, will determine if the research plan warrants the use of these samples. While the resource is open to both non-profit and commercial enterprises, preference will be given to academic investigators who have their research funded through a peer-reviewed process.
Please return all forms to the LCBRN Network Manager, Rebecca Blackwell, by e-mail, fax or mail:
Attn: Rebecca Blackwell
University of Virginia
Dept. of Pathology
Charlottesville, VA 22908
For any questions, please email email@example.com or call Rebecca Blackwell at (434) 982-6678.